Market closed

Dare Bioscience/$DARE

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Dare Bioscience

Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Ticker

$DARE
Trading on

Industry

Pharmaceuticals

Employees

25

Dare Bioscience Metrics

BasicAdvanced
$28M
Market cap
-
P/E ratio
-$0.43
EPS
-
Beta
-
Dividend rate
$28M
$7.56
$3.05
54K
1.136
0.893
-362.925
-396.999
-66.79%
191.07%
14.279
-18.6
-18.6
-3.113
88.13%
-92.45%
-61.87%

What the Analysts think about Dare Bioscience

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Dare Bioscience stock.

Dare Bioscience Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Dare Bioscience Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $DARE

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Dare Bioscience stock?

Dare Bioscience (DARE) has a market cap of $28M as of November 23, 2024.

What is the P/E ratio for Dare Bioscience stock?

The price to earnings (P/E) ratio for Dare Bioscience (DARE) stock is 0 as of November 23, 2024.

Does Dare Bioscience stock pay dividends?

No, Dare Bioscience (DARE) stock does not pay dividends to its shareholders as of November 23, 2024.

When is the next Dare Bioscience dividend payment date?

Dare Bioscience (DARE) stock does not pay dividends to its shareholders.

What is the beta indicator for Dare Bioscience?

Dare Bioscience (DARE) does not currently have a Beta indicator.